BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31552469)

  • 1. [Conjunctival malignancies].
    Auw-Hädrich C; Reinhard T
    Ophthalmologe; 2019 Oct; 116(10):989-1004. PubMed ID: 31552469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes--The 2017 J. Donald M. Gass Lecture.
    Shields CL; Chien JL; Surakiatchanukul T; Sioufi K; Lally SE; Shields JA
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):109-120. PubMed ID: 28399347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis of primary malignant tumors of the conjunctiva].
    Chebbi A; Bouguila H; Boukari M; Lajmi H; Bouzain M; Abess I; Malek I; Mrad K; Zeghal I; Nacef L
    J Fr Ophtalmol; 2015 Jun; 38(6):477-85. PubMed ID: 25976134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive conjunctival melanoma mimicking ocular surface squamous neoplasia: a case series.
    Gallo B; Thaung C; Hay G; Arora AK; Cohen VM; Damato B; Sagoo MS
    Br J Ophthalmol; 2021 Jun; 105(6):775-778. PubMed ID: 32675060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant conjunctival tumors invading the orbit.
    Gökmen Soysal H; Ardiç F
    Ophthalmologica; 2008; 222(5):338-43. PubMed ID: 18635931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant epibulbar tumours: new strategies in diagnostics and therapy].
    Westekemper H; Schallenberg M; Tomaszewski A; Nückel H; Sauerwein W; Meller D; Steuhl K
    Klin Monbl Augenheilkd; 2011 Sep; 228(9):780-92. PubMed ID: 21487989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A retrospective analysis of 147 cases of orbital exenteration].
    Zhao HS; Wei WB; Shi JT
    Zhonghua Yan Ke Za Zhi; 2023 May; 59(5):388-397. PubMed ID: 37151008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adjuvant contact radiotherapy for conjunctival malignancies: Preliminary results of a series of 14 patients treated with the Papillon 50 machine].
    Coquard R; N'Guyen AM; Mathis T; Josserand-Pietri F; Khodri M; Largeron G; Barbet N; Grange JD
    Cancer Radiother; 2018 Apr; 22(2):107-111. PubMed ID: 29475731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current Therapies in Superficial Malignant Tumors].
    Scholz SL; Eckstein A; Dekowski D; Esser J; Westekemper H; Steuhl KP
    Laryngorhinootologie; 2019 Oct; 98(10):685-694. PubMed ID: 31610596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the management of conjunctival melanoma.
    Vora GK; Demirci H; Marr B; Mruthyunjaya P
    Surv Ophthalmol; 2017; 62(1):26-42. PubMed ID: 27321895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy: conjunctival and eyelid tumors.
    Aronow ME; Singh AD
    Dev Ophthalmol; 2013; 52():85-93. PubMed ID: 23989129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].
    Kase S; Ishijima K; Noda M; Ishida S
    Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [777 cases of the primary conjunctival neoplasms].
    Feng G; Yi Y; Li Y
    Yan Ke Xue Bao; 1995 Dec; 11(4):211-5. PubMed ID: 9275748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current Therapies in Superficial Malignant Tumors].
    Scholz SL; Eckstein A; Dekowski D; Esser J; Westekemper H; Steuhl KP
    Klin Monbl Augenheilkd; 2018 Oct; 235(10):1138-1147. PubMed ID: 28898915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of a conjunctival keratoacanthoma requiring enucleation.
    Díaz Díaz AL; Tello A; Chaparro Tapias TA; Secondi R; Sánchez España JC
    Clin Ter; 2019; 170(2):e81-e83. PubMed ID: 30993300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review.
    Serbest Ceylanoglu K; Guneri Beser B; Singalavanija T; Juntipwong S; Worden FP; Demirci H
    Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):18-29. PubMed ID: 38241616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigmented conjunctival squamous cell carcinoma simulating a conjunctival melanoma.
    Shields JA; Shields CL; Eagle RC; Singh AD; Demirci H; Wolf MA
    Am J Ophthalmol; 2001 Jul; 132(1):104-6. PubMed ID: 11438062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
    Lommatzsch PK; Werschnik C
    Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.